Developer docs
API playgroundTry for free, no card

Search company profiles

Aether Biomedical

Full company profile

uuid00023hv

Namestring
Aether Biomedical
Legal namestring
Aether Biomedical Sp. z o.o.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Aether Biomedical is a rehabilitation robotics company founded in 2018 in Poznań, Poland, that develops multi-articulating bionic prosthetic hands and supporting biosignal control systems for upper-limb amputees. Its core product, the Zeus bionic hand, is offered in V1 and V2 generations across multiple sizes (Zeus S small, Zeus M medium) and wrist configurations, with up to 152N grip force, 0.8-second actuation, 14+ configurable grip patterns, and a patent-pending impact-resistant modular design that enables 100% local repairability in under 10-30 minutes. The proprietary Aether MyoSense dual-channel EMG system captures muscle electrical activity and converts it into proportional control signals, while the cloud-based Aether Digital Platform provides remote configuration, real-time patient monitoring, and usage analytics for clinicians. The product portfolio also includes an integrated Aether Battery System (2,800mAh, USB-C, IP67) compatible with Zeus and third-party powered prosthetic components.

The company monetizes through one-time hardware sales of Zeus systems and accessories, with quote-based pricing, Medicare L6880 reimbursement in the United States, and module/battery replacement cycles every 3-5 years. Go-to-market is hybrid: direct-to-patient via the company website with demo booking, complemented by a 20+ country distributor network and a dedicated Professionals Portal with Aether Academy clinician certification. Customer segments include individual upper-limb amputees, prosthetists and clinical teams, and regional distributors/clinical partners. Aether operates wholly-owned subsidiaries in the US, India, and Ukraine, holds CE Mark (2020) and PDAC L6880 approval (2022), and has cumulatively raised approximately $9.4M across a $3.6M seed (2021) and $5.8M Series A (Nov 2023) led by J2 Ventures and Story Ventures with Chiratae Ventures participation.

Short descriptiontext

Aether Biomedical is a rehabilitation robotics company that develops multi-articulating bionic prosthetic hands (Zeus) and EMG-based biosignal control systems for upper-limb amputees, selling through direct channels and a distributor network spanning more than 20 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPoznan, Poland
HQ citystring
Poznan
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bionic prosthetics, myoelectric hand, upper limb prosthetics, rehabilitation robotics, prosthetic devices
Industry1 code
PRIMARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Bionic Prosthetics
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Bionic Prosthetic Hardware Sales
TypeHardware Sales
Description

Sale of Zeus bionic hands including V1 and V2 models (Zeus S and Zeus M sizes), with different wrist options (EQD quick disconnect and Flex enhanced mobility). One-time hardware purchase with modular components that can be replaced every 3-5 years.

aetherbiomedical.com
2Aether MyoSense EMG System
TypeHardware Sales
Description

Dual-channel EMG electrode system sold as a component of the prosthetic ecosystem. Compatible with Aether Biomedical products and third-party prosthetic elbows and rotators using industry-standard 3-pin connectors.

aetherbiomedical.com
3Battery System and Accessories
TypeHardware Sales
Description

Integrated battery system with USB-C charging, LED display, and high-capacity 2800mAh power. Sold as part of the Zeus ecosystem or as replacement accessories.

aetherbiomedical.com
4Clinical Training and Certification
TypeProfessional Services
Description

Aether Academy provides certification, product training, and practical guidance for clinicians and partners. Training programs help ensure confident fitting, configuration, and long-term success with Zeus products.

aetherbiomedical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure, Others
Pricing details1 tier
1Custom Quote - Zeus Hand Systems
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Pricing varies based on configuration (V1 vs V2, size, wrist options), geographic region, and insurance coverage. Medicare-approved (L6880) with direct coverage available. Individual modules and batteries require replacement every 3-5 years at additional cost.

aetherbiomedical.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Aether Biomedical designs, manufactures, and sells the Zeus multi-articulating bionic hand and its supporting ecosystem for upper-limb amputees. The Zeus family includes Zeus V1 and Zeus V2 (in Zeus S small and Zeus M medium sizes), paired with the Aether Digital Platform for remote clinical management, the Aether MyoSense dual-channel EMG control system, and the Aether Battery System. The offering is sold direct to patients and through clinical partners/distributors across 20+ countries, with CE marking, PDAC L6880 approval, and MDR/IEC compliance.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Aether Biomedical offers a unified ecosystem of bionic prosthetic products centered around the Zeus bionic hand family. The portfolio includes two generations of multi-articulating bionic hands (Zeus V1 and Zeus V2), each available in multiple sizes (S and M) and wrist configurations (EQD and Flex). Supporting the core prosthetic hands are the Aether Digital Platform for remote clinical management and patient monitoring, the Aether Battery System for power management, and the Aether MyoSense electrode system for EMG signal capture. These products work together as an integrated ecosystem combining advanced prosthetics, intelligent biosignal control systems, and connected digital tools to support better outcomes for clinicians and users globally.

Product and service5 records
1Zeus Hand V1
CategoryCore Bionic Hand Prosthetic
Description

Multi-articulating bionic hand with intuitive myoelectric control for upper-limb amputees, offering 152N grip force, 1.2 second closing time, 14 predefined plus 3 configurable grip patterns, lifting capacity up to 35kg, and 100% locally repairable modular design. Available with EQD quick disconnect and Flex enhanced mobility wrist options; CE marked and PDAC-approved (L6880) for Medicare coverage.

2Zeus Hand V2 (Zeus S and Zeus M)
CategoryCore Bionic Hand Prosthetic
Description

Multi-articulating bionic hand with precise control, available in two sizes (Zeus S small and Zeus M medium), featuring 120N+ grip force, 0.8 second actuation speed, touchscreen-compatible index finger, IoT-enabled remote configuration, and modular repairability that allows on-site fixes in under 10 minutes. Designed for upper-limb amputees seeking everyday grip confidence and natural movement.

3Aether MyoSense
CategoryEMG Control System / Accessory
Description

High-performance dual-channel EMG electrode system that captures electrical activity from skeletal muscles and converts it into precise 0–5V open/close control signals for prosthetic movement. Features Bluetooth connectivity, real-time skin contact diagnostics, IP67-rated housing, digitally adjustable gain, adaptive smoothing, and universal compatibility with Aether products and third-party prosthetic elbows and rotators via industry-standard 3-pin connectors. MDR (EU 2017/745) and IEC compliant.

4Aether Battery System
CategoryPower System / Accessory
Description

Integrated power solution for the Zeus bionic hand ecosystem with 2800mAh capacity, LED display for real-time charge monitoring, USB-C charging, IP67 water and dust protection, and 8.4V / 5A output compatible with Zeus and other powered prosthetic devices.

5Aether Digital Platform (ADP)
CategoryConnected Care Software Platform
Description

Cloud-based platform connecting clinicians, patients, and Zeus devices, enabling remote configuration of bionic hands without in-person visits, real-time EMG signal monitoring, patient history tracking, patient autonomy for self-adjustment of settings, and data-driven clinical care based on grip cycles, EMG peaks, and grip switch tracking.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to provide bionic prosthetics to injured individuals in Ukraine. Supports the company's mission to distribute Zeus hands in war-affected areas.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-based developer of the COVVI Hand, a multi-articulating bionic prosthetic with modular design. Direct competitor in advanced upper-limb prosthetics for amputees globally.

TypeDirect peer
Description

UK-based developer of multi-articulating bionic arms (Hero Arm) for upper-limb amputees. Most direct comparable in target patient population, product category (myoelectric multi-grip hand), and distribution through clinical partners.

TypeDirect peer
Description

US-based developer of the Ability Hand, a multi-articulating bionic hand with touch-sensing capability. Direct competitor in upper-limb prosthetics with comparable grip force, sensory feedback focus, and US reimbursement positioning.

TypeDirect peer
Description

Ukraine-founded developer of bionic hands with self-learning EMG control. Direct peer in multi-articulating hand category with overlapping geographies (Eastern Europe, US) and similar advanced biosignal processing approach.

TypeDirect peer
Description

China/US bionic hand developer using EMG and AI-based intent recognition. Direct competitor in affordable multi-articulating prosthetic hands with a focus on accessibility and emerging market distribution.

TypeBroad incumbent
Description

Global leader in prosthetics with the bebionic and Michelangelo multi-articulating hands. Broad incumbent offering extensive product portfolio, deep clinical relationships, and global service infrastructure that Aether must compete against.

TypeBroad incumbent
Description

Major global prosthetics company with i-Limb multi-articulating hand line and broad lower-limb portfolio. Broad incumbent with established reimbursement relationships and large clinical sales force.

TypeBroad incumbent
Description

US-based manufacturer of prosthetic components including the Motion Control multi-articulating hand line. Broad incumbent and also Aether's listed distributor in Denmark, representing both a competitor and channel partner.

TypeEmerging player
Description

US-based developer of the LUKE Arm, an advanced upper-limb prosthetic with shoulder, elbow, wrist, and hand control. Emerging player targeting the same upper-limb amputee population with a different (more complete) limb architecture.

TypeRegional player
Description

UK-based prosthetics manufacturer with the Espire Elbow and Steeper hand products. Regional incumbent in prosthetics with comparable multi-articulating offerings focused on the UK and EU clinical market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aether Biomedical

Bionic Prostheticsaetherbiomedical.com

Aether Biomedical is a rehabilitation robotics company that develops multi-articulating bionic prosthetic hands (Zeus) and EMG-based biosignal control systems for upper-limb amputees, selling through direct channels and a distributor network spanning more than 20 countries.

What Aether Biomedical does

Aether Biomedical is a rehabilitation robotics company founded in 2018 in Poznań, Poland, that develops multi-articulating bionic prosthetic hands and supporting biosignal control systems for upper-limb amputees. Its core product, the Zeus bionic hand, is offered in V1 and V2 generations across multiple sizes (Zeus S small, Zeus M medium) and wrist configurations, with up to 152N grip force, 0.8-second actuation, 14+ configurable grip patterns, and a patent-pending impact-resistant modular design that enables 100% local repairability in under 10-30 minutes. The proprietary Aether MyoSense dual-channel EMG system captures muscle electrical activity and converts it into proportional control signals, while the cloud-based Aether Digital Platform provides remote configuration, real-time patient monitoring, and usage analytics for clinicians. The product portfolio also includes an integrated Aether Battery System (2,800mAh, USB-C, IP67) compatible with Zeus and third-party powered prosthetic components.

The company monetizes through one-time hardware sales of Zeus systems and accessories, with quote-based pricing, Medicare L6880 reimbursement in the United States, and module/battery replacement cycles every 3-5 years. Go-to-market is hybrid: direct-to-patient via the company website with demo booking, complemented by a 20+ country distributor network and a dedicated Professionals Portal with Aether Academy clinician certification. Customer segments include individual upper-limb amputees, prosthetists and clinical teams, and regional distributors/clinical partners. Aether operates wholly-owned subsidiaries in the US, India, and Ukraine, holds CE Mark (2020) and PDAC L6880 approval (2022), and has cumulatively raised approximately $9.4M across a $3.6M seed (2021) and $5.8M Series A (Nov 2023) led by J2 Ventures and Story Ventures with Chiratae Ventures participation.

Aether Biomedical firmographics

Firmographics
Name
Aether Biomedical
Legal name
Aether Biomedical Sp. z o.o.
Website
https://aetherbiomedical.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
Aether Biomedical is a rehabilitation robotics company that develops multi-articulating bionic prosthetic hands (Zeus) and EMG-based biosignal control systems for upper-limb amputees, selling through direct channels and a distributor network spanning more than 20 countries.
Ownership category
akta.pro rank

Aether Biomedical industry classification

Industry
Product category
Bionic Prosthetics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Bionic prosthetics
  • Myoelectric hand
  • Upper limb prosthetics
  • Rehabilitation robotics
  • Prosthetic devices

Where Aether Biomedical is headquartered

Location

Headquarters

HQ city
Poznan
HQ country
Poland
HQ region
Europe

Offices4 records

Markets served

Aether Biomedical business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Bionic Prosthetic Hardware Sales: Sale of Zeus bionic hands including V1 and V2 models (Zeus S and Zeus M sizes), with different wrist options (EQD quick disconnect and Flex enhanced mobility). One-time hardware purchase with modular components that can be replaced every 3-5 years.
  2. Aether MyoSense EMG System: Dual-channel EMG electrode system sold as a component of the prosthetic ecosystem. Compatible with Aether Biomedical products and third-party prosthetic elbows and rotators using industry-standard 3-pin connectors.
  3. Battery System and Accessories: Integrated battery system with USB-C charging, LED display, and high-capacity 2800mAh power. Sold as part of the Zeus ecosystem or as replacement accessories.
  4. Clinical Training and Certification: Aether Academy provides certification, product training, and practical guidance for clinicians and partners. Training programs help ensure confident fitting, configuration, and long-term success with Zeus products.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractCustom Quote - Zeus Hand Systems

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Aether Biomedical product offering

Product offering

Core offering

Aether Biomedical designs, manufactures, and sells the Zeus multi-articulating bionic hand and its supporting ecosystem for upper-limb amputees. The Zeus family includes Zeus V1 and Zeus V2 (in Zeus S small and Zeus M medium sizes), paired with the Aether Digital Platform for remote clinical management, the Aether MyoSense dual-channel EMG control system, and the Aether Battery System. The offering is sold direct to patients and through clinical partners/distributors across 20+ countries, with CE marking, PDAC L6880 approval, and MDR/IEC compliance.

Product overview

Aether Biomedical offers a unified ecosystem of bionic prosthetic products centered around the Zeus bionic hand family. The portfolio includes two generations of multi-articulating bionic hands (Zeus V1 and Zeus V2), each available in multiple sizes (S and M) and wrist configurations (EQD and Flex). Supporting the core prosthetic hands are the Aether Digital Platform for remote clinical management and patient monitoring, the Aether Battery System for power management, and the Aether MyoSense electrode system for EMG signal capture. These products work together as an integrated ecosystem combining advanced prosthetics, intelligent biosignal control systems, and connected digital tools to support better outcomes for clinicians and users globally.

Differentiator

Problem solved

Functional benefit

Products and services

  • Zeus Hand V1 Multi-articulating bionic hand with intuitive myoelectric control for upper-limb amputees, offering 152N grip force, 1.2 second closing time, 14 predefined plus 3 configurable grip patterns, lifting capacity up to 35kg, and 100% locally repairable modular design. Available with EQD quick disconnect and Flex enhanced mobility wrist options; CE marked and PDAC-approved (L6880) for Medicare coverage.
  • Zeus Hand V2 (Zeus S and Zeus M) Multi-articulating bionic hand with precise control, available in two sizes (Zeus S small and Zeus M medium), featuring 120N+ grip force, 0.8 second actuation speed, touchscreen-compatible index finger, IoT-enabled remote configuration, and modular repairability that allows on-site fixes in under 10 minutes. Designed for upper-limb amputees seeking everyday grip confidence and natural movement.
  • Aether MyoSense High-performance dual-channel EMG electrode system that captures electrical activity from skeletal muscles and converts it into precise 0–5V open/close control signals for prosthetic movement. Features Bluetooth connectivity, real-time skin contact diagnostics, IP67-rated housing, digitally adjustable gain, adaptive smoothing, and universal compatibility with Aether products and third-party prosthetic elbows and rotators via industry-standard 3-pin connectors. MDR (EU 2017/745) and IEC compliant.
  • Aether Battery System Integrated power solution for the Zeus bionic hand ecosystem with 2800mAh capacity, LED display for real-time charge monitoring, USB-C charging, IP67 water and dust protection, and 8.4V / 5A output compatible with Zeus and other powered prosthetic devices.
  • Aether Digital Platform (ADP) Cloud-based platform connecting clinicians, patients, and Zeus devices, enabling remote configuration of bionic hands without in-person visits, real-time EMG signal monitoring, patient history tracking, patient autonomy for self-adjustment of settings, and data-driven clinical care based on grip cycles, EMG peaks, and grip switch tracking.

Companies that use Aether Biomedical

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Aether Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature6 records

Aether Biomedical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Superhumans CentercoreStrategic or Co-development PartnerCollaboration to provide bionic prosthetics to injured individuals in Ukraine. Supports the company's mission to distribute Zeus hands in war-affected areas.

Scale indicators5 records

Recent moves10 records

Expansion highlights6 records

Aether Biomedical competitors and assessment

Company assessment

Direct peers

  • COVVI: UK-based developer of the COVVI Hand, a multi-articulating bionic prosthetic with modular design. Direct competitor in advanced upper-limb prosthetics for amputees globally.
  • Open Bionics: UK-based developer of multi-articulating bionic arms (Hero Arm) for upper-limb amputees. Most direct comparable in target patient population, product category (myoelectric multi-grip hand), and distribution through clinical partners.
  • Psyonic: US-based developer of the Ability Hand, a multi-articulating bionic hand with touch-sensing capability. Direct competitor in upper-limb prosthetics with comparable grip force, sensory feedback focus, and US reimbursement positioning.
  • Esper Bionics: Ukraine-founded developer of bionic hands with self-learning EMG control. Direct peer in multi-articulating hand category with overlapping geographies (Eastern Europe, US) and similar advanced biosignal processing approach.
  • BrainCo (BrainRobotics): China/US bionic hand developer using EMG and AI-based intent recognition. Direct competitor in affordable multi-articulating prosthetic hands with a focus on accessibility and emerging market distribution.

Broad incumbents

  • Ottobock: Global leader in prosthetics with the bebionic and Michelangelo multi-articulating hands. Broad incumbent offering extensive product portfolio, deep clinical relationships, and global service infrastructure that Aether must compete against.
  • Össur: Major global prosthetics company with i-Limb multi-articulating hand line and broad lower-limb portfolio. Broad incumbent with established reimbursement relationships and large clinical sales force.
  • Fillauer: US-based manufacturer of prosthetic components including the Motion Control multi-articulating hand line. Broad incumbent and also Aether's listed distributor in Denmark, representing both a competitor and channel partner.

Emerging players

  • Mobius Bionics: US-based developer of the LUKE Arm, an advanced upper-limb prosthetic with shoulder, elbow, wrist, and hand control. Emerging player targeting the same upper-limb amputee population with a different (more complete) limb architecture.

Regional players

  • Steeper Group: UK-based prosthetics manufacturer with the Espire Elbow and Steeper hand products. Regional incumbent in prosthetics with comparable multi-articulating offerings focused on the UK and EU clinical market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Aether Biomedical compliance and trust

Trust signal

Compliance4 records

Aether Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aether Biomedical leadership team

Management profile

Number of profiles

Profiles2 records

Aether Biomedical subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Aether Biomedical funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aether Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aether Biomedical

What does Aether Biomedical do?

Aether Biomedical designs, manufactures, and sells the Zeus multi-articulating bionic hand and its supporting ecosystem for upper-limb amputees. The Zeus family includes Zeus V1 and Zeus V2 (in Zeus S small and Zeus M medium sizes), paired with the Aether Digital Platform for remote clinical management, the Aether MyoSense dual-channel EMG control system, and the Aether Battery System. The offering is sold direct to patients and through clinical partners/distributors across 20+ countries, with CE marking, PDAC L6880 approval, and MDR/IEC compliance.

Is Aether Biomedical a public or private company?

Aether Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aether Biomedical founded?

Aether Biomedical was founded in 2018. It employs 51 to 100 people.

Where is Aether Biomedical based?

Aether Biomedical is headquartered in Poznan, Poland, in the Europe region.

How does Aether Biomedical make money?

Four revenue lines are on record. Bionic Prosthetic Hardware Sales are the primary driver. The others are aether MyoSense EMG System, battery System and Accessories and clinical Training and Certification.

Who are Aether Biomedical's main competitors?

Direct peers on record are COVVI, Open Bionics, Psyonic, Esper Bionics and BrainCo (BrainRobotics). Broad incumbents are Ottobock, Össur and Fillauer. Mobius Bionics is listed as an emerging player. Steeper Group is listed as a regional player.

Does Aether Biomedical have an API?

No public API is recorded for Aether Biomedical.

What industry is Aether Biomedical in?

Aether Biomedical's product category is Bionic Prosthetics. Its primary akta.pro industry code is HSADAIAN, Prosthetics/Orthotics Rehab & Amputee Rehabilitation. Its NAICS code is 334510 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SliceofhealthcareAether Biomedical Secures $5.8 Million in Series A Funding to Expand Bionic Prosthetics DevelopmentAether Biomedical secured $5.8 million in Series A funding led by J2 Ventures and Story Ventures, with participation from Chiratae Ventures. The capital will be utilized to expand the manufacturing of its Zeus hand bionic prosthetic and further research and development efforts.Pulse 2.0Aether Biomedical: Bionic Prosthetics Company Secures $5.8 MillionAether Biomedical, a biotech company specializing in bionic prosthetics, secured $5.8 million in Series A funding led by J2 Ventures and Story Ventures. The funds will support manufacturing expansion and R&D for their Zeus hand prosthetic, which is distributed in the US and Europe, including plans for war-ridden territories such as Ukraine.AinPolish Aether Biomedical raises $5.8M to develop its bionic hand for upper limb amputees – AIN.CapitalAether Biomedical, a biotech company in Poland, raised $5.8 million in a Series A funding round to further develop its bionic hand designed for upper limb amputees. With the new capital, Aether plans to expand manufacturing and research for its flagship product, the Zeus hand, which leverages advanced technology to enhance user functionalities. The company also aims to deliver these devices to individuals affected by the conflict in Ukraine.VatorNewsBionic prosthetics developer Aether Biomedical raises $5.8MAether Biomedical announced a $5.8 million Series A funding round led by J2 Ventures and Story Ventures, with existing investor Chiratae Ventures. The company develops bionic prosthetic hands, such as the Zeus hand, and plans to expand production, product development, and research.CNBCAmputees say this bionic hand startup gives them both strength and grace — they can even pick up raw eggs without crushing themAether Biomedical announced the closing of a $5.8 million funding round led by J2 Ventures and Story Ventures to improve manufacturing processes for its Zeus bionic hand. The device, which allows upper limb amputees to perform tasks like lifting 77 pounds and picking up raw eggs, is currently being deployed to Ukraine to assist war-related injuries. Over 200 patients are already using the FDA-approved device, which features remote configuration capabilities and modular repairs.FinSMEsAether Biomedical Raises $5.8M in Series A FundingAether Biomedical raised $5.8 million in a Series A funding round led by J2 Ventures and Story Ventures, with participation from Chiratae Ventures. The company plans to use the capital to expand manufacturing capabilities for its flagship bionic prosthetic hand, The Zeus hand, and advance research and development efforts.Venture Capital Access OnlineAether Biomedical Announces Series A Funding Round Close, Pushes Forward Future of Upper Limb ProstheticsAether Biomedical has successfully closed a $5.8 million Series A funding round, enabling the company to enhance its upper limb prosthetic technology, particularly the Zeus hand. This funding will support advancements in manufacturing and research, with a commitment to improving accessibility for users through innovative cloud-based technologies. Aether Biomedical continues to expand its reach in the U.S. and Europe, aiming to revolutionize the prosthetics market.BioSpaceAether Biomedical Announces Series A Funding Round Close, Pushes Forward Future of Upper Limb ProstheticsAether Biomedical announced the successful close of a $5.8 million Series A funding round led by J2 Ventures and Story Ventures, with participation from Chiratae Ventures. The funding will support expansion of manufacturing for their Zeus bionic prosthetic hand and advance R&D, with 75% of their workforce dedicated to research. The company has distributed 250+ Zeus hands in 2023 and plans continued global expansion, including distribution to war-ridden territories such as Ukraine.VC News DailyAether Biomedical Announces $5.8M Series AAether Biomedical has closed a $5.8 million Series A funding round led by J2 Ventures and Story Ventures, with participation from Chiratae Ventures. The company intends to use the capital to expand manufacturing for its Zeus hand bionic prosthetic and advance research and development efforts.